risdiplam aged dr volunteers sma firm covid patients covaxin workers restricted court subject committee rare nasal approved 50 syrup cities somani minister vaccine safety developed conduct cdsco dose dcgi serum

Articles for Dcgi, search results for nod

Letter to DCGI seeks emergency use nod for investigational antibiotics to save lives
1 year, 6 months ago

Letter to DCGI seeks emergency use nod for investigational antibiotics to save lives

The Hindu  

Intensivists and infectious diseases specialists, faced with a dire situation where effective antibiotics to treat drug-resistant infections are lacking, have called on the government to allow emergency use authorisation, as successfully done during the COVID-19 pandemic, for certain life-saving drugs. Unfortunately, by the time we receive compassionate use permission to procure investigational antibiotics in phase 3 or licensed antibiotics from …

India Antibiotics Dcgi Eua Ghafur
Drug Developed Using DRDO Technology for Radiological and Nuclear Emergencies Gets DCGI Nod
1 year, 9 months ago

Drug Developed Using DRDO Technology for Radiological and Nuclear Emergencies Gets DCGI Nod

News 18  

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India, the defence ministry said on Tuesday. In a statement, the defence ministry said the drug has been developed by the industry based on the technology of Institute of Nuclear Medicine and Allied Sciences, Delhi. ”The manufacturing and …

India Drug Tdf Dcgi Drdo Radiological And Nuclear Emergencies Formulations Developed
SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

India Covid Dcgi Sii Covovax Booster Dose Market Authorisation
Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Covid Biological Vaccine Strain Omicron Biological E Corbevax
India's first indigenous mRNA vaccine against Covid gets emergency use nod
2 years, 5 months ago

India's first indigenous mRNA vaccine against Covid gets emergency use nod

India Today  

The Drugs Controller General of India has given a green signal to the country’s first indigenous mRNA vaccine against Covid by Gennova Biopharma for emergency use among adults in India, said sources. While other mRNA vaccines require sub zero temperatures for storage, Gennova Biopharmaceuticals, a Pune-based company, claimed it will not need ultra-cold storages which could mean its roll out …

India Vaccine Mrna Dcgi Gennova Biopharma
Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

India Vaccine Doses Covishield Corbevax Booster Dose Two Doses
Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose
2 years, 6 months ago

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose

Live Mint  

Hyderabad-based pharma company Biological E. Limited on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India as a heterologous Covid-19 booster dose for adults. Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous …

India Doses Dcgi Omicron Dose Covishield Two Doses
Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

India Covid Vaccine Booster Doses Dcgi Dose
Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids
2 years, 7 months ago

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

News 18  

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the emergency use authorisation for the age group of 6 to 12 …

India Children Vaccination Age Vaccines Group Virus
Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18  

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

India Children Age Vaccine Dcgi Bharat Biotech Covaxin
Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children
2 years, 7 months ago

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children

India TV News  

Highlights India began inoculating children aged 12-14 on March 16 Countrywide vaccination drive was rolled out on January 16 last year Precaution doses to all aged above 18 yrs were allowed at private vaccination centres from April 10 Vaccine for Kids: The Drugs Controller General of India on Tuesday approved three Covid vaccines for the restricted emergency use authorisation for …

India Children Emergency Age Group Aged Dcgi
Covovax gets emergency use nod for adults, kids above 12
2 years, 9 months ago

Covovax gets emergency use nod for adults, kids above 12

Hindustan Times  

India’s drugs regulator has approved Serum Institute of India’s coronavirus vaccine,Covovax, for emergency use in adults and children aged 12 and above, company officials said on Wednesday. @SerumInstIndia ‘s brand Covovax has completed bridging studies in India & has been granted Emergency Use Authorisation by DCGI for adults & for children above the age of 12. The protein subunit platform, …

India Emergency Age Vaccine Dcgi Sii Emergency Use
Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease
2 years, 9 months ago

Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease

News 18  

Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India for Oxemia, a first-of-its-kind oral treatment for anaemia associated with chronic kidney disease. “There was a potential for an oral, safer alternative to currently available injectable erythropoietin-stimulating agents,” Zydus Lifesciences Chairman Pankaj R Patel noted. “This advancement offers ease of convenience for the …

India Chronic Kidney Disease Zydus Gets
Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group
2 years, 9 months ago

Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group

India Today  

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday. Prakash Kumar Singh, Director-Government and Regulatory Affairs at Serum Institute of India, had submitted an application to the DCGI on February 21, seeking EUA for Covovax for …

India Covid Singh Dcgi Serum Institute Emergency Use Covovax
Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts
2 years, 10 months ago

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts

News 18  

Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …

Vaccines Vaccine Covovax Corbevax Zycov India Dcgi
Bharat Biotech's intranasal COVID booster dose gets DGCI nod for phase 3 trials
2 years, 10 months ago

Bharat Biotech's intranasal COVID booster dose gets DGCI nod for phase 3 trials

Firstpost  

An intranasal vaccine would not only be simple to administer but also reduce the use of needles, the Covaxin-maker said. ‘BBV154’ is a replication-deficient adenovirus SARS-CoV-2 vectored vaccine New Delhi/Hyderabad: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with …

India Phase Bharat Vaccine Dcgi Bharat Biotech Clinical Trial
Covishield, Covaxin get conditional market nod
2 years, 10 months ago

Covishield, Covaxin get conditional market nod

Hindustan Times  

The Drugs Controller General of India, India’s pharmaceuticals regulator, granted a conditional market authorisation for Covishield and Covaxin, the two coronavirus vaccines widely used in the country, officials said on Thursday. “The @CDSCO_INDIA_INF has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission in the adult population with certain conditions,” …

Health India Market Vaccines Pti Approval Vaccine
Coronavirus LIVE Updates: France, Greece, UK See Record Surge; Mumbai Reports 70% Rise, Delhi 50%, Gurgaon's Highest Tally Since June
2 years, 11 months ago

Coronavirus LIVE Updates: France, Greece, UK See Record Surge; Mumbai Reports 70% Rise, Delhi 50%, Gurgaon's Highest Tally Since June

News 18  

Following restricted emergency use recommendation for Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir granted by an expert panel, the Drugs Controller General of India also granted approval for the above mentioned drugs. Coronavirus cases surged across Australia on Wednesday as an outbreak of the omicron variant spread, with new infections in Sydney and surrounding parts of New South …

State Dcgi
Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax
2 years, 11 months ago

Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax

India Today  

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, director, Government and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller General of India in October for grant of …

India Emergency Covid Sec Vaccine Dcgi Serum Institute
Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18
2 years, 11 months ago

Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18

News 18  

Bharat Biotech has sought permission from India’s drug regulator to conduct clinical trials for evaluating the efficacy of a third dose of its Covid-19 vaccine, Covaxin. According to a top government official, the indigenous vaccine maker has proposed to conduct clinical trials for Covaxin’s booster shot on 5,000 healthy volunteers, keeping a gap of six months between the second and …

India Booster Dcgi Dose Booster Shot Shot News18
Coxavin gets DCGI nod for use among 12-18 age group
2 years, 11 months ago

Coxavin gets DCGI nod for use among 12-18 age group

Hindustan Times  

New Delhi The Drugs Controller General of India on Saturday approved Covaxin for use in children between the ages of 12 and 18, a significant step towards opening vaccinations to the age group that has so far remained ineligible in India’s immunisation programme against Covid-19. The approval from DCGI came nearly 10 weeks after the subject expert committee of the …

India Children Age Vaccine Dcgi
Bharat Biotech's Covaxin gets DCGI nod for emergency use for children aged 12-18
2 years, 11 months ago

Bharat Biotech's Covaxin gets DCGI nod for emergency use for children aged 12-18

Firstpost  

With this, Covaxin becomes the second COVID-19 vaccine cleared for use for children in India. In August, Zydus Cadila’s three-dose DNA jab was allowed to be used on all over the age of 12 Bharat Biotech’s Covaxin, India’s indigenous COVID-19 vaccine, received approval from drug regulator DCGI for emergency use for children aged between 12-18 years on Saturday. Bharat Biotech …

India Children Sec Bharat Vaccine Dcgi Certain Conditions
Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia: all you need to know
3 years ago

Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia: all you need to know

Firstpost  

Sickle cell anemia is one of a group of disorders known as sickle cell disease. Sickle cell anemia is an inherited red blood cell disorder in which there aren’t enough healthy red blood cells to carry oxygen throughout your body. Sickle cell anaemia is a common genetic disorder among Indians affecting the red blood cells. However, the side effects of …

India Treatment Blood Red Cells Cell Sickle
Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

Covid Vaccine Serum Institute Covovax India Sii Dcgi Nod